Sagent Pharmaceuticals Recalls Four Lots of Levetiracetam
Sagent Pharmaceuticals issued a recall for four lots of Levetiracetam Injection, USP due to a lack of sterility assurance. Levetiracetam is used for the treatment of certain types of seizures. Intravenous administration of a product intended to be sterile that is not sterile could result in serious systemic infections which may be life threatening. Lot numbers recalled include BOG85VB, BOK88VA, BOK89VA, and B1G194A.